1. Home
  2. STRO vs SUJA Comparison

STRO vs SUJA Comparison

Compare STRO & SUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$8.89

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Logo Suja Life Inc. Class A Common Stock

SUJA

Suja Life Inc. Class A Common Stock

HOLD

Current Price

$9.74

Market Cap

215.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRO
SUJA
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
181.4M
215.3M
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
STRO
SUJA
Price
$8.89
$9.74
Analyst Decision
Strong Buy
Buy
Analyst Count
14
7
Target Price
★ $47.23
$18.40
AVG Volume (30 Days)
★ 279.9K
194.1K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $38,419,000.00
N/A
Revenue This Year
N/A
$10.73
Revenue Next Year
N/A
$12.60
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.72
$5.59
52 Week High
$43.85
$12.42

Technical Indicators

Market Signals
Indicator
STRO
SUJA
Relative Strength Index (RSI) 21.28 45.59
Support Level N/A $8.83
Resistance Level $16.99 $10.94
Average True Range (ATR) 1.24 0.64
MACD -0.18 -0.21
Stochastic Oscillator 7.84 4.12

Price Performance

Historical Comparison
STRO
SUJA

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About SUJA Suja Life Inc. Class A Common Stock

Suja Life Inc operates a beverage platform focused on producing and selling products such as cold-pressed juices, wellness shots, and functional sodas. Its portfolio includes brands such as Suja Organic, Vive Organic, and Slice. The Company operates and manages its business in two operating segments, which are also reportable segments: i) Suja Core: It produces and distributes cold-pressed fresh juice and cold-pressed juice shots. ii) Emerging Brands: It consists of recently acquired or launched brands and products that are still in the early stages of revenue scale, market development, or distribution build-out. The majority of revenue is derived from Suja Core.

Share on Social Networks: